Deciphera Pharmaceuticals, Inc. Operating Expenses
Deciphera Pharmaceuticals, Inc. reported Operating Expenses of $75.32 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-05-05
- Deciphera Pharmaceuticals, Inc. operating expenses for the quarter ending 2020-03-31 was $75.32M, a 53.64% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating expenses for the quarter ending 2019-12-31 was $70.37M, a 108.02% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating expenses for the quarter ending 2019-09-30 was $58.35M, a 125.40% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating expenses for the quarter ending 2019-06-30 was $47.98M, a 113.90% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating expenses for fiscal 2019 was $225.73M, a 116.84% increase from fiscal 2018.
- Deciphera Pharmaceuticals, Inc. operating expenses for fiscal 2018 was $104.10M, a 104.38% increase from fiscal 2017.
- Deciphera Pharmaceuticals, Inc. operating expenses for fiscal 2017 was $50.94M, a 97.13% increase from fiscal 2016.
- Deciphera Pharmaceuticals, Inc. operating expenses for fiscal 2016 was $25.84M, a 46.72% increase from fiscal 2015.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-03-31 | $75.32M 10-Q · filed 2020-05-05 | $145.70M derived: sum of 2 quarters · filed 2020-05-05 | $204.05M derived: sum of 3 quarters · filed 2020-05-05 | $252.03M derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-12-31 | $70.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $128.73M derived: sum of 2 quarters · filed 2020-03-09 | $176.70M derived: sum of 3 quarters · filed 2020-03-09 | $225.73M 10-K · filed 2020-03-09 |
| 2019-09-30 | $58.35M 10-Q · filed 2019-11-04 | $106.33M derived: sum of 2 quarters · filed 2019-11-04 | $155.35M 10-Q · filed 2019-11-04 | $189.18M derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-06-30 | $47.98M 10-Q · filed 2019-08-02 | $97.00M 10-Q · filed 2019-08-02 | $130.83M derived: sum of 3 quarters · filed 2020-05-05 | $156.72M derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-03-31 | $49.02M 10-Q · filed 2020-05-05 | $82.86M derived: sum of 2 quarters · filed 2020-05-05 | $108.74M derived: sum of 3 quarters · filed 2020-05-05 | $131.17M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $33.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $59.72M derived: sum of 2 quarters · filed 2020-03-09 | $82.15M derived: sum of 3 quarters · filed 2020-03-09 | $104.10M 10-K · filed 2020-03-09 |
| 2018-09-30 | $25.89M 10-Q · filed 2019-11-04 | $48.32M derived: sum of 2 quarters · filed 2019-11-04 | $70.27M 10-Q · filed 2019-11-04 | $90.61M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | $22.43M 10-Q · filed 2019-08-02 | $44.38M 10-Q · filed 2019-08-02 | $64.72M derived: sum of 3 quarters · filed 2020-03-09 | $76.90M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | $21.95M 10-Q · filed 2019-05-09 | $42.29M derived: sum of 2 quarters · filed 2020-03-09 | $54.47M derived: sum of 3 quarters · filed 2020-03-09 | $65.16M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | $20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $32.52M derived: sum of 2 quarters · filed 2020-03-09 | $43.21M derived: sum of 3 quarters · filed 2020-03-09 | $50.94M 10-K · filed 2020-03-09 |
| 2017-09-30 | $12.18M 10-Q · filed 2018-11-08 | $22.87M derived: sum of 2 quarters · filed 2018-11-08 | $30.60M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $10.69M 10-Q · filed 2018-08-07 | $18.42M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $7.73M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $25.84M 10-K · filed 2019-03-14 | |||
| 2015-12-31 | $17.61M 10-K · filed 2018-03-28 |